What Weight-Loss Drugs Reveal About How We Judge Effort

Why we trust visible struggle more than invisible change.

Updated March 28, 2026 | Reviewed by Monica Vilhauer Ph.D.

Imagine watching two people try to lose weight.

One struggles constantly—resisting cravings, forcing exercise, fighting the same urges every day. The effort is obvious. You can see the work. The other loses weight more quietly. They still make changes, but the process looks smoother, less dramatic. There is less visible struggle.

Most people instinctively trust the first story more.

This reflects a simple psychological shortcut: We equate visible difficulty with effort. When change looks hard, we assume determination. When it looks easier, we assume something is missing.

But this shortcut is often wrong.

Attribution research shows that people tend to overestimate how much outcomes reflect effort and underestimate the role of underlying conditions. Much of what determines how difficult change feels happens out of view. Differences in biology, psychology, and life circumstances can make the same goal dramatically harder for one person than another.

Because those differences are largely invisible, we rely on what we can see: behavior and results. Difficulty becomes proof that change is legitimate. If something looks too easy, we question whether it really counts.

Few domains reveal this dynamic more clearly than weight.

For decades, body weight has functioned as a kind of visible scorecard. However imperfectly, it has been treated as evidence of discipline, motivation , and self-control . Weight loss is often read as effort rewarded; weight gain as effort lacking.

This interpretation persists despite growing evidence that weight regulation is shaped by complex biological systems.

GLP-1 medications challenge not just how weight changes, but how we interpret the effort behind it. These drugs act on hormones that regulate appetite , satiety, and blood sugar. Clinical trials show that medications like semaglutide can reduce body weight by 10–15 percent on average, largely by reducing hunger and food reward.

Research increasingly shows that weight regulation involves interacting systems governing hunger, metabolism, and reward sensitivity. These differences are often subtle but cumulative. Two people can follow similar strategies and experience very different levels of difficulty because their biology is not the same. One person’s system may amplify hunger and cravings; another’s may not.

What makes this psychologically important is that these differences are mostly invisible. What others see is whether someone loses weight. What they cannot see is how difficult it was to get there.

GLP-1 medications make this gap easier to notice because they change some of the biological conditions shaping appetite. Patients often report not just weight loss, but a shift in the experience of trying to lose weight: less persistent hunger, fewer intrusive food thoughts, and less need for constant vigilance.

Effort is not eliminated. But it operates under different conditions.

From the outside, however, weight loss that appears smoother is often interpreted as requiring less determination. This reflects another shortcut: We infer effort from visible struggle. When struggle is obvious, we assume commitment. When it is not, we assume the opposite.

Research on weight stigma shows how strongly this pattern is reinforced by beliefs about controllability. When people believe a condition is under personal control, they are more likely to attach moral judgment to it. Because weight has long been framed in behavioral terms, like “eat less, move more,” it has often been interpreted through a moral lens rather than a biological one.

GLP-1 medications complicate that story. They challenge a familiar cultural assumption: that weight is primarily a reflection of how hard someone tries. When that assumption becomes less certain, people struggle to interpret what they are seeing.

There is also a quieter psychological dynamic at work. People evaluate change relative to their own experience. If you have spent years struggling to lose weight, watching someone else lose more with less visible effort can evoke confusion, resentment, or even grief . When new tools change what is possible, expectations about effort and fairness shift. This adjustment is not unusual; similar reactions have followed many medical advances.

What stands out is how strongly people still rely on visible effort to make sense of change. Effort feels concrete, observable, and fair. Biological variation is harder to see and harder to incorporate into everyday judgments about who deserves credit.

So, GLP-1 medications may be doing something subtle beyond their medical effects. By making the biological context of weight regulation more visible, they may begin to reshape how we think about effort itself. If the difficulty of change is not evenly distributed, visible struggle may not be the best indicator of determination.

This points to a broader psychological question: What does it mean to be accurately seen?

In this context, being seen is less about praise than about being understood with reasonable accuracy. When effort is interpreted through overly simple stories—like lack of discipline or unfair shortcuts—people are not just judged; they are misread.

And that misreading has consequences. Weight stigma does not simply disappear with weight loss. It often shifts. People who lose weight with medication may face a different kind of judgment, which is less about a failure of discipline and more about the assumption that their success was unearned. In both cases, the underlying issue is the same: Effort is being inferred from incomplete information.

Research shows that stigma, whether tied to weight itself or to how weight is lost, can undermine health by increasing stress , discouraging engagement in care, and eroding trust in providers. People who experience weight-related stigma are more likely to avoid medical appointments, report lower-quality care, and have worse mental health outcomes. In that sense, a more accurate understanding is not simply kinder. It may also support better outcomes.

Medical advances often change more than treatment; they reshape how conditions are understood. As biological influences become more visible, explanations tend to shift from simple behavioral narratives toward more complex models that include physiology, psychology, and environment. Weight has always been visible. What may be changing is how we interpret what we see.

And in everyday life—where we rarely know the full story behind someone else’s progress—recognizing how much effort remains invisible may help us judge others, and ourselves, with greater accuracy and compassion.

Major, B., Hunger, J. M., Bunyan, D. P., & Miller, C. T. (2014). The ironic effects of weight stigma. Journal of Experimental Social Psychology, 51 , 74–80.

Puhl, R. M., & Heuer, C. A. (2010). Obesity stigma: Important considerations for public health. American Journal of Public Health, 100 (6), 1019–1028.

Rubino, D. M., et al (2022). Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): A randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. The Lancet Diabetes & Endocrinology , 10 (3), 193–206.

Share this post Facebook Bluesky Linkedin Email

There was a problem adding your email address. Please try again.

By submitting your information you agree to the Psychology Today Terms & Conditions and Privacy Policy

Tara Well, Ph.D. , is a professor in the department of psychology at Barnard College of Columbia University.

Get the help you need from a therapist near you–a FREE service from Psychology Today.

This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.